Back to search

Article

Optimizing efficacy to safety ratio of glucocorticoids in rheumatoid arthritis models by leveraging PPARα agonism

2025-10-15

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objectives</h4> Glucocorticoids remain essential therapies for several immune- and inflammatory diseases such as rheumatoid arthritis (RA) but are notorious for their (metabolic) side effects. Given the anti-inflammatory and metabolically favorable actions of peroxisome-proliferator activated nuclear receptor (PPAR) agonists, we investigated whether PPARα agonism could enhance the therapeut...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0e28910b-42f2-5beb-8077-d815e39b59dc
DOI
10.1101/2025.10.14.682304
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimizing efficacy to safety ratio of glucocorticoids in rheumatoid arthritis models by leveraging PPARα agonismDOI 10.1101/2025.10.14.682304
Select a neighboring publication to make it the new centre.